Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?

Tropical Medicine and International Health

Volumn 13, Issue 2, 2008, Pages 229-237

  Nebie, I ^a   Tiono, A B ^a   Diallo, D A ^a   Samandoulougou, S ^b   Diarra, A ^a   Konate, A T ^a   Cuzin Ouattara, N ^a   Theisen, M ^c   Corradin, G ^d   Cousens, S ^e   Ouattara, A S ^b   Ilboudo Sanogo, E ^a   Sirima, B S ^a  

^a Burkina Faso   (Burkina Faso)

^b UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^c Department of Clinical Biochemistry Statens Serum ^*  (Denmark)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Antibody response; Malaria; Transmission intensity; Vaccine candidate antigens

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; MALARIA VACCINE;

ANTIBODY; ANTIGEN; COHORT ANALYSIS; DISEASE TRANSMISSION; HEALTH SURVEY; IMMUNE RESPONSE; MALARIA; VACCINE; VILLAGE;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH SURVEY; HUMAN; HUMORAL IMMUNITY; INCIDENCE; MALARIA; MALE; PLASMODIUM FALCIPARUM; PREVALENCE; RISK FACTOR;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BURKINA FASO; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; HUMANS; IMMUNOGLOBULIN G; INFANT; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SEASONS;

PLASMODIUM FALCIPARUM;

EID: 39849094730     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2007.01994.x     Document Type: Article

References (28)

1. Askjaer N, Maxwell C, Chambo W et al. (2001) Insecticide-treated bed nets reduce plasma antibody levels and limit the repertoire of antibodies to Plasmodium falciparum variant surface antigens. Clinical and Diagnostic Laboratory Immunology 8, 1289 1291.
2. Chumpitazi B, Lepers JP, Rason M, Meunier A, Boudin C Ambroise-Thomas P (1993) Circulating stable antigens at higher levels down-regulate antibody responses to Plasmodium falciparum. Parasitology Research 79, 163 167.
3. Del Giudice G, Verdini AS, Pinori M et al. (1987) Detection of human antibodies against Plasmodium falciparum sporozoites using synthetic peptides. Journal of Clinical Microbiology 25, 91 96.
4. Dodoo D, Theisen M, Kurtzhals JA et al. (2000) Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria. Journal of Infectious Diseases 181, 1202 1205.
5. Drakeley CJ, Corran PH, Coleman PG et al. (2005) Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proceedings of the National Academy of Sciences USA 102, 5108 5113.
6. Esposito F, Lombardi S, Modiano D et al. (1988) Prevalence and levels of antibodies to the circumsporozoite protein of Plasmodium falciparum in an endemic area and their relationship to resistance against malaria infection. Transactions of the Royal Society of Tropical Medicine and Hygiene 82, 827 832.
7. Farid M (1980) The malaria programme - from euphoria to anarchy. World Health Forum 1, 8 33.
8. Habluetzel A, Cuzin N, Diallo DA et al. (1999) Insecticide-treated curtains reduce the prevalence and intensity of malaria infection in Burkina Faso. Tropical Medicine & International Health 4, 557 564.
9. Jakobsen PH, Theander TG, Hviid L et al. (1996) Antibody reactivities to glutamate-rich peptides of Plasmodium falciparum parasites in humans from areas of different malaria endemicity. Apmis 104, 734 740.
10. Kariuki SK, Lal AA, Terlouw DJ et al. (2003) Effects of permethrin-treated bed nets on immunity to malaria in western Kenya II. Antibody responses in young children in an area of intense malaria transmission. American Journal of Tropical Medicine and Hygiene 68, 108 114.
11. Lengeler C, Armstrong-Schellenberg J, D'Alessandro U, Binka F Cattani J (1998) Relative versus absolute risk of dying reduction after using insecticide-treated nets for malaria control in Africa. Tropical Medicine & International Health 3, 286 290.
12. Lines J (1996) Review: mosquito nets and insecticides for net treatment: a discussion of existing and potential distribution systems in Africa. Tropical Medicine & International Health 1, 616 632.
13. Marsh K, Hayes RH, Carson DC et al. (1988) Anti-sporozoite antibodies and immunity to malaria in a rural Gambian population. Transactions of the Royal Society of Tropical Medicine and Hygiene 82, 532 537.
14. McGregor IA (1964) The passive transfer of human malarial immunity. American Journal of Tropical Medicine and Hygiene 13 (Suppl. 237 239.
15. Meraldi V, Nebie I, Tiono AB et al. (2004) Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection. Parasite Immunology 26, 265 272.
16. Modiano D, Petrarca V, Sirima BS et al. (1998) Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. American Journal of Tropical Medicine and Hygiene 59, 336 340.
17. Molineaux L Gramiccia G (1980) The Garki Project. World Health Organisation, Geneva.
18. Nebie I, Cuzin-Ouattara N, Diallo DA et al. (2003) Humoral responses to defined malaria antigens in children living since birth under insecticide treated curtains in Burkina Faso. Acta Tropics 88, 17 25.
19. Oeuvray C, Bouharoun-Tayoun H, Gras-Masse H et al. (1994a) Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood 84, 1594 1602.
20. Oeuvray C, Bouharoun-Tayoun H, Grass-Masse H et al. (1994b) A novel merozoite surface antigen of Plasmodium falciparum (MSP-3) identified by cellular-antibody cooperative mechanism antigenicity and biological activity of antibodies. Memorias do Instituto Oswaldo Cruz 89 (Suppl. 2 77 80.
21. Oeuvray C, Theisen M, Rogier C, Trape JF, Jepsen S Druilhe P (2000) Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal. Infection and Immunity 68, 2617 2620.
22. Otoo LN, Riley EM, Menon A, Byass P Greenwood BM (1989) Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 778 782.
23. Petersen E, Hogh B, Dziegiel M et al. (1992) The antibody response to well-defined malaria antigens after acute malaria in individuals living under continuous malaria transmission. Acta Tropics 51, 135 142.
24. Sabchareon A, Burnouf T, Ouattara D et al. (1991) Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. American Journal of Tropical Medicine and Hygiene 45, 297 308.
25. Singer LM, Mirel LB, ter Kuile FO et al. (2003) The effects of varying exposure to malaria transmission on development of antimalarial antibody responses in preschool children. XVI. Asembo Bay Cohort Project. Journal of Infectious Diseases 187, 1756 1764.
26. Soe S, Theisen M, Roussilhon C, Aye KS Druilhe P (2004) Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infection and Immunity 72, 247 252.
27. Theisen M, Vuust J, Gottschau A, Jepsen S Hogh B (1995) Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. Clinical and Diagnostic Laboratory Immunology 2, 30 34.
28. Theisen M, Soe S, Oeuvray C, Thomas AW et al. (1998) The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infection and Immunity 66, 11 17.